NCT02134457View on ClinicalTrials.gov

Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Retinopathy of Prematurity (ROP)
Interventions
BIOLOGICAL

ranibizumab

Trial Locations (9)

24105

University Eye Hospital, Kiel

39120

University Eye Hospital, Magdeburg

40225

University Eye Hospital, Düsseldorf

48149

University Eye Hospital, Münster

53127

University Eye Hospital, Bonn

72076

University Eye Hospital, Tübingen

79106

University Eye Hospital, Freiburg im Breisgau

80336

University Eye Hospital, Munich

93053

University Eye Hospital, Regensburg

All Listed Sponsors
lead

University Hospital Freiburg

OTHER

NCT02134457 - Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity | Biotech Hunter | Biotech Hunter